A 73-year-old man with a nonproductive cough that began while taking lisinopril for three months, continued after discontinuing lisinopril four weeks ago and after switching to losartan, how should the cough be evaluated and managed?

ACE Inhibitor-Induced Cough Still Present After 4 Weeks—Wait Longer

This patient's persistent cough 4 weeks after stopping lisinopril is likely still ACE inhibitor-induced, as resolution can take up to 3 months in a subgroup of patients, and you should discontinue losartan and wait an additional 8 weeks before pursuing other causes 1.

Understanding the Timeline

The ACCP guidelines clearly state that while ACE inhibitor-induced cough typically resolves within 1-4 weeks of cessation, resolution may be delayed in a subgroup of patients for up to 3 months 1. Your patient is only 4 weeks out from stopping lisinopril, placing him well within this extended resolution window.

Why Losartan Isn't Helping (And What to Do About It)

The ARB Paradox in This Case

While ARBs like losartan have a significantly lower incidence of cough compared to ACE inhibitors (17-29% vs 62-72% in patients with prior ACE inhibitor cough) 2, 3, 4, there are critical nuances:

• Losartan can still cause cough in 17-29% of patients with prior ACE inhibitor cough 2, 3—this is not zero
• Rare case reports document losartan-induced cough that resolved when switched back to an ACE inhibitor 5, though this is exceptional
• The ongoing cough may represent persistent ACE inhibitor effects, not losartan-induced cough

Immediate Action Required

Stop the losartan now 1. The guidelines recommend switching to an ARB when ACE inhibitor cough is confirmed and resolved, but this patient's cough never resolved. You're potentially layering one cough-inducing medication on top of residual effects from another.

Algorithmic Approach to Management

Step 1: Medication Washout (Current Priority)

• Discontinue losartan immediately
• Switch to an alternative antihypertensive class entirely (e.g., calcium channel blocker, beta-blocker, or thiazide diuretic depending on comorbidities)
• Wait an additional 8 weeks (total of 12 weeks from lisinopril cessation) to allow complete resolution 1

Step 2: Evaluate for Other Causes During Waiting Period

While waiting, assess for red flags that would mandate immediate workup 6:

• Hemoptysis (immediate chest imaging and specialist referral)
• Smoker >45 years with new/changed cough (consider lung cancer screening)
• Prominent dyspnea, especially at rest or night (evaluate for heart failure, interstitial lung disease)
• Systemic symptoms: fever, weight loss, night sweats
• Hoarseness (laryngeal pathology)

If none present, the nonproductive nature and temporal relationship to lisinopril strongly support drug-induced etiology.

Step 3: Reassess at 12 Weeks Post-Lisinopril

If cough persists at 12 weeks:

• Now evaluate as chronic cough (>8 weeks duration) 6
• Pursue common causes: upper airway cough syndrome (postnasal drip), asthma, gastroesophageal reflux disease, nonasthmatic eosinophilic bronchitis 6
• Consider chest X-ray if not already done
• Use validated cough severity assessment tool to track response to interventions 6

If cough resolves:

• Diagnosis of ACE inhibitor-induced cough confirmed
• Can cautiously retry an ARB if renin-angiotensin system blockade is compelling for this patient (e.g., heart failure, diabetic nephropathy, post-MI) 1
• Choose a different ARB than losartan given the unclear picture
• Monitor closely for cough recurrence

Critical Pitfalls to Avoid

1. Don't assume 4 weeks is enough: The 1-4 week resolution timeframe is typical, not universal. Up to 3 months is documented 1.

2. Don't continue losartan: While ARBs are the recommended alternative for confirmed ACE inhibitor cough, this patient's cough never resolved before starting losartan. You cannot distinguish between persistent ACE inhibitor effects and potential losartan contribution.

3. Don't pursue extensive workup prematurely: In a 73-year-old, the temptation is to image and scope immediately. However, the temporal relationship to lisinopril initiation and nonproductive nature strongly suggest drug-induced etiology. Allow adequate washout time unless red flags emerge.

4. Don't restart ACE inhibitors: While guidelines note that cough may not recur in a minority of patients upon rechallenge 1, this is not recommended as initial management and should only be considered if there's a compelling reason and after complete resolution 1.

The Evidence Hierarchy

The ACCP guidelines 1 provide Grade A and B recommendations based on systematic evidence. The FDA label data 2 confirms losartan's lower but non-zero cough incidence. Multiple RCTs 3, 4, 7 consistently show 17-29% cough rates with losartan in ACE inhibitor cough patients—significantly better than ACE inhibitors (62-72%) but not equivalent to placebo (35%).

The key insight: Your patient hasn't had adequate time off the ACE inhibitor to make any determination about losartan's role.